Regeneron Surrenders Most Early Gains After Q3 Beat By: Benzinga via Benzinga November 08, 2017 at 14:29 PM EST Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares are trading higher by $1.50 at $405.89 in Wednesday's session. Before the open, ... Read More >> Related Stocks: Regeneron Pharmaceuticals